WallStreetZenWallStreetZen

NYSE: INSP
Inspire Medical Systems Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INSP

Based on 12 analysts offering 12 month price targets for Inspire Medical Systems Inc

Min Forecast
$39.00-42.75%
Avg Forecast
$59.33-12.9%
Max Forecast
$85.00+24.78%

Should I buy or sell INSP stock?

Based on 12 analysts offering ratings for Inspire Medical Systems Inc.

Hold
Strong Buy
2 analysts 16.67%
Buy
2 analysts 16.67%
Hold
7 analysts 58.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 8.33%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their INSP stock forecasts and price targets.

INSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
Piper Sandler
Top 29%
72
HoldMaintains$60.00-11.92%2026-08-04
Baird
Top 27%
74
HoldMaintains$59.00-13.39%2026-08-04
UBS
Bottom 11%
11
Strong SellAssumes$39.00-42.75%2026-07-28
Freedom Capital Markets
Bottom 41%
41
Strong BuyInitiates Coverage On$62.00-8.98%2026-07-01
Stifel Nicolaus
Bottom 12%
12
Strong BuyMaintains$65.00-4.58%2026-05-05

1 of 2

Forecast return on equity

Is INSP forecast to generate an efficient return?

Company
10.18%
Industry
22.81%
Market
168.91%
INSP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INSP forecast to generate an efficient return on assets?

Company
9.08%
Industry
13.67%
INSP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INSP earnings per share forecast

What is INSP's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$0.32-93.04%
Avg 2 year Forecast
$1.43-68.95%
Avg 3 year Forecast
$2.04-55.58%
INSP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

INSP revenue forecast

What is INSP's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$868.5M-3.36%
Avg 2 year Forecast
$901.8M+0.34%
Avg 3 year Forecast
$962.1M+7.05%
INSP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INSP earnings growth forecast

How is INSP forecast to perform vs Medical Devices companies and vs the US market?

Company
-22.41%
Industry
22.1%
Market
30.89%
INSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
INSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
INSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

INSP revenue growth forecast

How is INSP forecast to perform vs Medical Devices companies and vs the US market?

Company
2.1%
Industry
7.31%
Market
13.25%
INSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INSP vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
INSP$68.12$59.33-12.90%Hold
ALMR$27.77$33.00+18.83%Strong Buy
BFLY$7.12N/AN/A
ESTA$71.39$101.17+41.71%Strong Buy
UFPT$277.40N/AN/A
View Top Medical Device Stocks

Inspire Medical Systems Stock Forecast FAQ

Is Inspire Medical Systems Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: INSP) stock is to Hold INSP stock.

Out of 12 analysts, 2 (16.67%) are recommending INSP as a Strong Buy, 2 (16.67%) are recommending INSP as a Buy, 7 (58.33%) are recommending INSP as a Hold, 0 (0%) are recommending INSP as a Sell, and 1 (8.33%) are recommending INSP as a Strong Sell.

If you're new to stock investing, here's how to buy Inspire Medical Systems stock.

What is INSP's earnings growth forecast for 2026-2028?

(NYSE: INSP) Inspire Medical Systems's forecast annual earnings growth rate of -22.41% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.89%.

Inspire Medical Systems's earnings in 2026 is $135,042,000.On average, 19 Wall Street analysts forecast INSP's earnings for 2026 to be $9,239,756, with the lowest INSP earnings forecast at -$7,083,042, and the highest INSP earnings forecast at $38,551,985. On average, 19 Wall Street analysts forecast INSP's earnings for 2027 to be $41,200,175, with the lowest INSP earnings forecast at $24,082,342, and the highest INSP earnings forecast at $54,033,491.

In 2028, INSP is forecast to generate $58,951,146 in earnings, with the lowest earnings forecast at $43,631,538 and the highest earnings forecast at $75,282,617.

What is INSP's revenue growth forecast for 2026-2028?

(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 2.1% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.25%.

Inspire Medical Systems's revenue in 2026 is $898,742,000.On average, 20 Wall Street analysts forecast INSP's revenue for 2026 to be $25,109,527,999, with the lowest INSP revenue forecast at $23,402,370,355, and the highest INSP revenue forecast at $26,163,889,375. On average, 20 Wall Street analysts forecast INSP's revenue for 2027 to be $26,071,954,383, with the lowest INSP revenue forecast at $23,685,692,030, and the highest INSP revenue forecast at $27,575,293,883.

In 2028, INSP is forecast to generate $27,815,828,203 in revenue, with the lowest revenue forecast at $26,001,702,171 and the highest revenue forecast at $29,690,955,125.

What is INSP's forecast return on assets (ROA) for 2026-2029?

(NYSE: INSP) forecast ROA is 9.08%, which is lower than the forecast US Medical Devices industry average of 13.67%.

What is INSP's Price Target?

According to 12 Wall Street analysts that have issued a 1 year INSP price target, the average INSP price target is $59.33, with the highest INSP stock price forecast at $85.00 and the lowest INSP stock price forecast at $39.00.

On average, Wall Street analysts predict that Inspire Medical Systems's share price could fall to $59.33 by Aug 4, 2027. The average Inspire Medical Systems stock price prediction forecasts a potential downside of 12.9% from the current INSP share price of $68.12.

What is INSP's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: INSP) Inspire Medical Systems's current Earnings Per Share (EPS) is $4.59. On average, analysts forecast that INSP's EPS will be $0.32 for 2026, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at $1.33. On average, analysts forecast that INSP's EPS will be $1.43 for 2027, with the lowest EPS forecast at $0.83, and the highest EPS forecast at $1.87. In 2028, INSP's EPS is forecast to hit $2.04 (min: $1.51, max: $2.60).

What is INSP's forecast return on equity (ROE) for 2026-2029?

(NYSE: INSP) forecast ROE is 10.18%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.